• Home
  • About Us
    Our Approach Our Team Board
  • Pipeline
  • News
  • Honor
  • Careers
  • Collaboration
  • Investor Relations
    Disclosure Contact IR
  • Contact
中文 ENG
    • Home
    • About us
      • Our Approach
      • Our Team
      • Board
    • Pipeline
    • News
    • Honor
    • Careers
    • Collaboration
    • Investor Relations
      • Disclosure
      • Contact IR
    • Contact
    • CN

COMPANY NEWS

Category Company News Enterprise Honor
2022 05

27

TYK Medicines collaborates with Syneos Health to conduct TY-2136b Phase I clinical trial in the United States

Discover More
2022 03

22

TY-9591 Phase II study in patients with EGFRm NSCLC and brain metastases was successfully initiated at the Affiliated Cancer Hospital of Chinese Academy of Medical Sciences

Discover More
2022 02

28

TYK Medicines Successfully Passed the Postdoctoral Workstation Certification

Discover More
2022 01

07

TYK Medicines Completes Series C Financing of 330 Million Yuan, Led by Huge Capital

Discover More
2022 01

01

TYK Medicines, Inc was Recognized as a New Type of Research and Development Institution

Discover More
2021 12

27

TYK Medicines, Inc was Awarded for two Individual “National Foreign Expert Project” by the Ministry of Science and Technology for the First Time

Discover More
<34567>
CN ENG
  • Home
  • About Us
  • Pipeline
  • News
  • Honor
  • Careers
  • Investors
  • Contact
Powered by SE

Copyright © 2019 浙江同源康 版权所有 浙ICP备19008464号